Pharmaresources: Announcement of Shanghai Hongbo Zhigen Pharmaceutical Co., Ltd.'s acquisition of investment fund shares and external investment
Pharmaresources: Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Pharmaresources: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Pharmaresources: Legal opinion from Jia Yuan Law Firm in Beijing regarding the second interim shareholder meeting of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. in 2024.
Pharmaresources: Announcement regarding the addition of proposals and supplementary notice for the second extraordinary shareholders' meeting in 2024.
Pharmaresources: Notice of the Second Extraordinary Shareholders' Meeting in 2024
Pharmaresources: Announcement regarding changes to the registered capital of the company, amendment of the company's articles of association, and filing of industrial and commercial change registration.
Pharmaresources: Revision of the Articles of Association of Shanghai Hongbo Zhigen Pharmaceutical Co., Ltd.
Pharmaresources: Legal Opinion of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.
Pharmaresources: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hongbo Pharmaceutical: Report of the Audit Committee of the Board of Directors on the firm's evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Hongbo Pharmaceutical: Notice on the holding of the 2023 Annual General Meeting of Shareholders
Hongbo Pharmaceutical: 2023 Internal Control Self-Evaluation Report
Hongbo Pharmaceutical: Announcement on the 2024 Mid-Term Profit Distribution Plan
Hongbo Pharmaceutical: Announcement on Accruing Credit Impairment Losses and Asset Impairment Losses in 2023
Hongbo Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Hongbo Pharmaceutical: Legal Opinion of Beijing Jiayuan Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.
Hongbo Pharmaceutical: Board Remuneration and Assessment Committee Work Rules
Hongbo Pharmaceutical: Notice on the holding of the 2024 First Extraordinary General Meeting of Shareholders
Hongbo Pharmaceutical: Rules of Work of the Nomination Committee of the Board of Directors
No Data